Import Freight in Mexico: How Pharma Investment Is Reshaping Logistics
Written by María Gamba
Mexico is stepping up its game in the global pharmaceutical market — and logistics companies should take note. With the government’s latest decree favoring pharmaceutical companies that produce locally, Mexico is positioning itself as a strategic hub for medicine manufacturing. But this isn’t just big news for the pharma sector; it’s a major development for import freight and the entire supply chain ecosystem in Mexico.
This blog breaks down what the new government measure means, why logistics providers need to prepare, and how import freight demand is about to shift in exciting ways.
A Strategic Move to Attract Pharma Investment
In a recent announcement, Eduardo Clark, Undersecretary of Integration and Development at the Ministry of Health, outlined a new government plan that will prioritize pharmaceutical companies with manufacturing plants in Mexico during the federal medicine procurement processes starting in 2026.
This decree aims to:
Promote domestic production of medicines
Reduce reliance on foreign suppliers
Boost employment
Make medications more affordable for Mexican citizens
The goal? To attract investment from pharmaceutical giants in India, the U.S., Europe, and Latin America by offering incentives for companies that build or expand operations in Mexico.
Why It Matters for Logistics and Import Freight
Behind every pharmaceutical product lies a complex network of logistics: active ingredients, packaging materials, lab equipment, and even specialized refrigeration units. As pharmaceutical production in Mexico increases, so too will the demand for import freight services.
Key impacts on the logistics industry:
Increased import freight volume: Companies setting up new factories will need to bring in equipment, raw materials, and high-tech infrastructure.
More specialized shipments: Pharmaceutical logistics requires temperature control, traceability, and speed. Logistics companies will need to evolve.
Regional distribution opportunities: Local plants will not only serve Mexico but also potentially supply other countries, creating new export logistics routes.
Mexico’s Competitive Advantage
Mexico already has strong free trade agreements, a skilled labor force, and proximity to the U.S. These factors make it a highly attractive destination for foreign pharma companies looking to relocate or diversify operations. The new decree only adds to the appeal.
But there’s another advantage: Mexico’s logistics sector — especially companies like Control Terrestre — is ready to handle the challenge.
At Control Terrestre, we specialize in connecting businesses with smart, flexible transport solutions. As import freight volumes rise, we’re committed to offering seamless, tailored services that keep the pharmaceutical supply chain moving efficiently and compliantly.
What Logistics Providers Should Be Doing Now
If you’re in the logistics space, this decree should serve as a wake-up call. Here’s how to prepare:
Invest in pharma-compliant infrastructure
Temperature-controlled trucks, proper tracking systems, and qualified personnel will become more critical.Strengthen partnerships with pharma suppliers
Start building relationships with companies entering or expanding in Mexico. Offer them solutions — not just services.Enhance customs and import processes
Import freight operations for pharmaceutical goods require speed, accuracy, and transparency. Now is the time to optimize.Stay ahead of regulations
As new investment pours in, compliance will be key. Ensure your company is up-to-date with health and trade regulations.
Looking Beyond 2026
The decree goes into effect in 2026, but the groundwork is being laid now. Pharma companies are scouting locations, planning production lines, and exploring logistics partnerships. The growth in import freight needs won’t wait for 2026 — it starts now.
And it’s not just about getting goods into the country. As Mexico becomes a production hub, there will be more complexity in distribution, reverse logistics, and last-mile delivery, especially for sensitive or time-critical medicines.
A Win-Win for Mexico
This isn’t just good news for pharmaceutical companies — it’s a win for Mexico’s economy, healthcare system, and logistics providers.
More investment means:
Better access to affordable medications
More jobs in both pharma and logistics
Stronger integration with global supply chains
A new leadership role for Mexico in the global medicine trade
At Control Terrestre, we believe that smart logistics isn’t just about transporting cargo — it’s about enabling industries, improving lives, and helping Mexico thrive.
Final Thoughts
Mexico is betting on its future as a pharmaceutical powerhouse — and logistics is the backbone that will make it happen. With demand for import freight set to grow rapidly, the logistics sector has an opportunity to innovate, adapt, and lead.
Whether you’re a pharmaceutical executive or a supply chain strategist, now is the time to act. The future is arriving — one shipment at a time.